Gardasil News and Research

RSS

Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.

Novel test could improve detection of cervical adenocarcinoma

In findings with potentially important implications for cervical cancer screening, scientists at the National Cancer Institute (NCI)-designated Montefiore Einstein Cancer Center (MECC) have developed a test for detecting a type of cervical cancer that Pap tests often miss.

7 Sep 2023

Understanding the cervical microbiome: a promising frontier in HPV treatment

A recent feature published in PNAS provided emerging insights into microflora associated with human papillomavirus (HPV) infections.

26 Apr 2023

Rutgers study uncovers predictors of anal high-risk HPV infection

Previous sexually transmitted infections and more sexual partners predict new human papillomavirus (HPV) infections in men who have sex with men, other cisgender sexual minority men and transgender women, according to a Rutgers study.

7 Sep 2022

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Australia's first dedicated children's immunotherapy center will investigate treatments to not only increase the survival of kids with cancer, but to also improve their ongoing quality of life.

24 Aug 2022

Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

A recent report suggested that a single dose of the human papillomavirus (HPV) vaccination confers equivalent immunity to a two-dose schedule against cervical cancers caused by HPV.

14 Apr 2022

Cervical cancer screening behaviors differ between vaccinated and unvaccinated women

Women who are vaccinated against human papillomavirus (HPV) are more likely to undergo cervical cancer screenings than unvaccinated women, according to new research by Penn State College of Medicine.

7 Dec 2021

Trial positions single-dose HPV vaccination as a high impact public health intervention

In the push to eliminate cervical cancer, researchers delivered hopeful news Nov. 17 at the 34th International Papillomavirus Conference in Toronto.

20 Nov 2021

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

A new study published in the preprint server bioRxiv in September 2020 reports on the structure of this protein, as revealed by cryo-electron microscopy (cryoEM).

23 Sep 2020

Federal experts’ advice on HPV vaccine could leave adults confused

Vaccination decisions are usually pretty straightforward. People either meet the criteria for the vaccine based on their age or other factors or they don't. But when a federal panel recently recommended an update to the human papillomavirus (HPV) vaccine guidelines, it left a lot of uncertainty.

8 Aug 2019

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

6 Oct 2018

Sylvester dermatologist uses HPV vaccine to treat patient with squamous cell tumors

Squamous cell carcinoma is the second-most-common form of skin cancer. Evidence suggests the human papilloma virus plays a role in the development of some types of this skin cancer.

3 Jul 2018

HPV vaccine shows long-term safety and efficacy in protecting against most virulent strains

A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report.

29 Nov 2017

The ratcheting cost of the pneumococcal vaccine: What gives?

Every November, like clockwork, she gets the same letter, said Dr. Lindsay Irvin, a pediatrician in San Antonio.

29 Nov 2017

HPV-related oropharyngeal cancer risk remains generally low, study suggests

The prevalence of throat (oropharyngeal) cancers caused by the human papilloma virus (HPV) has increased in recent decades, and some groups are much more likely than others to have the oral HPV infections that can cause these cancers.

20 Oct 2017

Five important things everyone should know about cervical cancer

There are several types of gynecologic cancers that affect the female reproductive system, including endometrial, ovarian, cervical, vaginal and vulvar cancer.

3 Oct 2017

Newest vaccine highly effective at preventing nine types of HPV infection, study shows

Cervical cancer is the second most common cause of cancer-related death worldwide, with almost 300,000 deaths occurring each year. More than 80 percent of these deaths occur in developing nations.

7 Sep 2017

Study finds long-term effectiveness of HPV vaccine in preventing cervical cancer

A vaccine that can literally eradicate the majority of cervical cancer cases shows long-term effectiveness in a study published today in The Lancet.

6 Sep 2017

HPV vaccination may be beneficial for CKD patients but not for kidney transplant recipients

Human papillomavirus (HPV) vaccination stimulates robust and sustained immune responses in girls and young women with chronic kidney disease (CKD) and those on dialysis, but less optimal responses to the vaccine were observed among those with a kidney transplant.

11 Apr 2016

European regulator concludes that evidence does not support a causal relationship between human papillomavirus vaccines and CRPS or POTS

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a detailed scientific review of the evidence surrounding reports of two syndromes, complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS) in young women given human papillomavirus (HPV) vaccines.

10 Nov 2015

UofL evaluates safety of new therapeutic vaccine in women with HPV 16, 18 infections

Cervical cancer is the fourth most frequently occurring cancer in women. Human papillomavirus (HPV) is present in 99 percent of cervical cancers and is considered to be their cause. While most HPV infections will clear naturally within a few years, there has been no treatment available to hasten or improve the chance of natural eradication.

31 Oct 2015